203 related articles for article (PubMed ID: 21712991)
1. Serum soluble HLA-E in melanoma: a new potential immune-related marker in cancer.
Allard M; Oger R; Vignard V; Percier JM; Fregni G; Périer A; Caignard A; Charreau B; Bernardeau K; Khammari A; Dréno B; Gervois N
PLoS One; 2011; 6(6):e21118. PubMed ID: 21712991
[TBL] [Abstract][Full Text] [Related]
2. Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy.
Ugurel S; Rebmann V; Ferrone S; Tilgen W; Grosse-Wilde H; Reinhold U
Cancer; 2001 Jul; 92(2):369-76. PubMed ID: 11466692
[TBL] [Abstract][Full Text] [Related]
3. Detection of soluble HLA-G molecules in plasma and amniotic fluid.
Rebmann V; Pfeiffer K; Pässler M; Ferrone S; Maier S; Weiss E; Grosse-Wilde H
Tissue Antigens; 1999 Jan; 53(1):14-22. PubMed ID: 10082427
[TBL] [Abstract][Full Text] [Related]
4. Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release.
Morandi F; Levreri I; Bocca P; Galleni B; Raffaghello L; Ferrone S; Prigione I; Pistoia V
Cancer Res; 2007 Jul; 67(13):6433-41. PubMed ID: 17616704
[TBL] [Abstract][Full Text] [Related]
5. Secretion of sHLA-G molecules in malignancies.
Rebmann V; Regel J; Stolke D; Grosse-Wilde H
Semin Cancer Biol; 2003 Oct; 13(5):371-7. PubMed ID: 14708717
[TBL] [Abstract][Full Text] [Related]
6. Soluble HLA-G: purification from eukaryotic transfected cells and detection by a specific ELISA.
Fournel S; Aguerre-Girr M; Campan A; Salauze L; Berrebi A; Lone YC; Lenfant F; Le Bouteiller P
Am J Reprod Immunol; 1999 Jul; 42(1):22-9. PubMed ID: 10429763
[TBL] [Abstract][Full Text] [Related]
7. Soluble HLA class I antigens in plasma of patients with malignant melanoma.
Westhoff U; Fox C; Otto FJ
Anticancer Res; 1998; 18(5B):3789-92. PubMed ID: 9854497
[TBL] [Abstract][Full Text] [Related]
8. [Determination of soluble HLA class I molecules in children in bone marrow transplantation].
Sedivá A; Starý J; Hromadníková I; Skalická A; Ghio M
Cas Lek Cesk; 2000 Oct; 139(20):630-4. PubMed ID: 11192758
[TBL] [Abstract][Full Text] [Related]
9. Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction.
Puppo F; Contini P; Ghio M; Indiveri F
ScientificWorldJournal; 2002 Feb; 2():421-3. PubMed ID: 12806026
[TBL] [Abstract][Full Text] [Related]
10. Quantification and identification of soluble HLA-G isoforms.
Rebmann V; LeMaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
Tissue Antigens; 2007 Apr; 69 Suppl 1():143-9. PubMed ID: 17445190
[TBL] [Abstract][Full Text] [Related]
11. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004.
Rebmann V; Lemaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
Hum Immunol; 2005 Aug; 66(8):853-63. PubMed ID: 16216668
[TBL] [Abstract][Full Text] [Related]
12. Relationship between soluble HLA-G and HLA-A,-B,-C serum levels, and interferon-gamma production after sublingual immunotherapy in patients with allergic rhinitis.
Ciprandi G; Continia P; Fenoglio D; Sormani MP; Negrini S; Puppo F; Indiveri F
Hum Immunol; 2008 Jul; 69(7):409-13. PubMed ID: 18573288
[TBL] [Abstract][Full Text] [Related]
13. Serum sHLA-G levels: a useful indicator in distinguishing colorectal cancer from benign colorectal diseases.
Zhu CB; Wang CX; Zhang X; Zhang J; Li W
Int J Cancer; 2011 Feb; 128(3):617-22. PubMed ID: 20473865
[TBL] [Abstract][Full Text] [Related]
14. HLA-E polymorphism and soluble HLA-E plasma levels in chronic hepatitis B patients.
Zidi I; Laaribi AB; Bortolotti D; Belhadj M; Mehri A; Yahia HB; Babay W; Chaouch H; Zidi N; Letaief A; Yacoub S; Boukadida J; Di Luca D; Hannachi N; Rizzo R
HLA; 2016 Mar; 87(3):153-9. PubMed ID: 26956431
[TBL] [Abstract][Full Text] [Related]
15. Impact of blood processing on estimation of soluble HLA-G.
Poláková K; Bandžuchová E; Russ G
Neoplasma; 2011; 58(4):337-42. PubMed ID: 21520991
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis.
Fainardi E; Rizzo R; Melchiorri L; Castellazzi M; Paolino E; Tola MR; Granieri E; Baricordi OR
Mult Scler; 2006 Feb; 12(1):2-12. PubMed ID: 16459714
[TBL] [Abstract][Full Text] [Related]
17. A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells.
Rizzo R; Campioni D; Stignani M; Melchiorri L; Bagnara GP; Bonsi L; Alviano F; Lanzoni G; Moretti S; Cuneo A; Lanza F; Baricordi OR
Cytotherapy; 2008; 10(4):364-75. PubMed ID: 18574769
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of soluble form of HLA class I molecule in Japanese patients with pancreatic cancer.
Shimura T; Tsutsumi S; Hosouchi Y; Kojima T; Kon Y; Yonezu M; Kuwano H
Hum Immunol; 2001 Jun; 62(6):615-9. PubMed ID: 11390036
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a competitive enzyme-linked immunosorbent assay for measurements of soluble HLA-G protein.
Rasmussen M; Dahl M; Buus S; Djurisic S; Ohlsson J; Hviid TV
Tissue Antigens; 2014 Aug; 84(2):206-15. PubMed ID: 24785939
[TBL] [Abstract][Full Text] [Related]
20. [Method of detection of soluble HLA-I and soluble HLA-I level alteration in storage blood].
Lan JC; Wu T; Zhou HY; Zhang YZ; Wei YM; Lai ZF; Cao Q; Yang QK; Wu DL; Liu Z
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):363-7. PubMed ID: 15228668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]